Business · 21/09/2020
FDA Announces Final Guidance for Investigational COVID-19 Convalescent Plasma
The FDA is releasing a final guidance document that provides recommendations for healthcare providers on the use of investigational convalescent plasma to treat COVID-19, superseding a previous guidance from April 2020
Original source language: Federal Register — Food and Drug AdministrationOpen original release →